BICX (BioCorRx) Debt-to-Asset : 4.32 (As of Sep. 2024)

View and export this data going back to 2009. Start your Free Trial

What is BioCorRx Debt-to-Asset?

BioCorRx's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $2.54 Mil. BioCorRx's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $0.24 Mil. BioCorRx's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was $0.64 Mil. BioCorRx's debt to asset for the quarter that ended in Sep. 2024 was 4.32.

BioCorRx Debt-to-Asset Historical Data

The historical data trend for BioCorRx's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioCorRx Debt-to-Asset Chart

BioCorRx Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

0.21

0.52

2.02

2.19

4.66

BioCorRx Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Asset	Get a 7-Day Free Trial															3.07	4.66	6.89	4.50	4.32

Competitive Comparison of BioCorRx's Debt-to-Asset

For the Medical Care Facilities subindustry, BioCorRx's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioCorRx's Debt-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, BioCorRx's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where BioCorRx's Debt-to-Asset falls into.

BioCorRx Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

BioCorRx's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(1.729	+	0.083)	/	0.389
	=	4.66

BioCorRx's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(2.543	+	0.241)	/	0.644
	=	4.32

BioCorRx (OTCPK:BICX) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

BioCorRx Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of BioCorRx's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

BioCorRx Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BioCorRx Inc (OTCPK:BICX) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

2390 East Orangewood Avenue, Suite 500, Anaheim, CA, USA, 92806

Website

https://www.biocorrx.com

BioCorRx Inc through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders. The BioCorRx Recovery Program is a non-addictive, medication assisted treatment program for substance abuse that includes peer recovery support. The UnCraveRx Weight Loss Management Program is a medically assisted weight management program that is combined with a virtual platform application.

Executives

Louis C. Lucido	director	2390 EAST ORANGEWOOD AVENUE, SUITE 500, ANAHEIM CA 92806
Joseph J Galligan	director, 10 percent owner	333 SOUTH GRAND AVENUE, 18TH FLOOR, LOS ANGELES CA 90071
Harsha Murthy	director	5209 38TH STREET,NW, WASHINGTON DC 20015
Luisa Ingargiola	director	4826 BLUE JAY CIRCLE, PALM HARBOR FL 34683
Thomas Patrick Welch	officer: Vice President of Operations	10453 SARAH ST., TOLUCA LAKE CA 91602
Kent Emry	director, officer: Chief Executive Officer	2390 EAST ORANGEWOOD AVENUE, SUITE 500, ANAHEIM CA 92806
Brady James Granier	director	13024 DELANO STREET, VALLEY GLEN CA 91401
Lourdes Felix	director, officer: Chief Financial Officer	15 CALLE VERANO, RANCHO SANTA MARGARITA CA 92688
Jorge Jr Andrade	director, officer: Chief Executive Officer	PO BOX 5366, SANTA ANA CA 92704
Muller Neil Terrence Mr	director, officer: President	13231 SANDHURST PLACE, SANTA ANA CA 92705